Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/28/2000 | WO2000078961A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/28/2000 | WO2000078960A2 Compositions and methods for the therapy and diagnosis of breast cancer |
12/28/2000 | WO2000078959A1 Human genes and proteins encoded thereby |
12/28/2000 | WO2000078958A2 Scorpion toxins from buthotus judaicus |
12/28/2000 | WO2000078957A2 Scorpion toxins from buthotus judaicus |
12/28/2000 | WO2000078956A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
12/28/2000 | WO2000078955A1 Epithelial cell growth inhibitors |
12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
12/28/2000 | WO2000078953A2 Human transport proteins |
12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
12/28/2000 | WO2000078951A1 Chimeric oca-b transcription factors |
12/28/2000 | WO2000078950A2 Differentially expressed genes in the adipocytes of obese mice |
12/28/2000 | WO2000078948A2 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor |
12/28/2000 | WO2000078947A1 Head trauma induced cytoplasmatic calcium binding protein |
12/28/2000 | WO2000078944A1 Methods to design and identify new plant resistance genes |
12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
12/28/2000 | WO2000078940A1 In vivo insect model system for type-2 diabetes |
12/28/2000 | WO2000078938A1 Molecular modeling for metalloproteins |
12/28/2000 | WO2000078934A2 Use of the ubiquitin specific protease usp25 in the diagnosis and treatment of alzheimer's disease |
12/28/2000 | WO2000078930A1 Method for enhancing hematopoiesis |
12/28/2000 | WO2000078927A2 Spheroid preparation |
12/28/2000 | WO2000078921A2 Shank proteins and methods of use thereof |
12/28/2000 | WO2000078813A2 Huntington disease cellular model: stably transfected pc12 cells expressing mutant huntingtin |
12/28/2000 | WO2000078811A1 Human antithrombin variants |
12/28/2000 | WO2000078810A1 Surfactant protein c esters |
12/28/2000 | WO2000078809A1 Axor16, a g protein coupled receptor |
12/28/2000 | WO2000078808A1 Secreted proteins and uses thereof |
12/28/2000 | WO2000078807A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
12/28/2000 | WO2000078806A1 Mage-a1 peptides presented by hla class ii molecules |
12/28/2000 | WO2000078805A1 Peptide having preptin functionality |
12/28/2000 | WO2000078804A1 Immune response regulatory proteins |
12/28/2000 | WO2000078803A2 Use of eif4e binding agents in therapy |
12/28/2000 | WO2000078802A2 Secreted polypeptides and corresponding polynucleotides |
12/28/2000 | WO2000078801A2 Insulin-like growth factor agonist molecules |
12/28/2000 | WO2000078799A2 Mlo-genes controlling diseases |
12/28/2000 | WO2000078792A1 Method for purification of proteins |
12/28/2000 | WO2000078788A1 NOVEL cDNA ASSOCIATED WITH RENAL DISEASE |
12/28/2000 | WO2000078787A1 ISOLATED GENES FROM VIRULENT GROUP B $i(STREPTOCOCCUS AGALACTIAE) |
12/28/2000 | WO2000078786A1 galK |
12/28/2000 | WO2000078785A1 lacA |
12/28/2000 | WO2000078784A1 treP |
12/28/2000 | WO2000078780A1 FabZ |
12/28/2000 | WO2000078360A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
12/28/2000 | WO2000078337A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
12/28/2000 | WO2000078334A1 Chimeric chemokine-antigen polypeptides and uses therefor |
12/28/2000 | WO2000078329A2 The use of the protein uk 114 for inhibiting organ transplant rejection |
12/28/2000 | WO2000078266A2 Interferon tau mutants and methods for making them |
12/28/2000 | WO2000078119A2 Cardiomyocytes with enhanced proliferative potential |
12/28/2000 | WO2000058460A3 Casb619 involved in colon cancers |
12/28/2000 | WO2000056903A3 IMPROVED METHODS FOR PRODUCING PROTEINS IN TRANSFORMED $i(PICHIA) |
12/28/2000 | WO2000056353A3 A uro-genital condition treatment system |
12/28/2000 | WO2000055336A3 Ve protein and nucleic acid sequences, compositions, and methods for plant pathogen resistance |
12/28/2000 | WO2000053767A3 Nucleic acid respiratory syncytial virus vaccines |
12/28/2000 | WO2000053729A3 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
12/28/2000 | WO2000053724A3 Compositions and methods for the modification of gene transcription |
12/28/2000 | WO2000052181A3 Gcn4-derived expression of heterologous coding sequences and different uses thereof |
12/28/2000 | WO2000052050A3 Homology models of the glucocorticoid receptor |
12/28/2000 | WO2000050594A3 Mammalian alpha-helical protein, zsig83 |
12/28/2000 | WO2000050074A3 Neisserial vaccine compositions and methods |
12/28/2000 | WO2000049162A3 Compositions and methods for non-targeted activation of endogenous genes |
12/28/2000 | WO2000048625A3 Inhibitors for use in hemostasis and immune function |
12/28/2000 | WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes |
12/28/2000 | WO2000046343A3 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
12/28/2000 | WO2000044898A3 Novel agouti and agouti-related peptide analogs |
12/28/2000 | WO2000043495A3 33 human secreted proteins |
12/28/2000 | WO2000037640A3 Compositions and methods for the treatment of tumor |
12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
12/28/2000 | WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
12/28/2000 | WO2000030667A3 Compositions and methods using lactadherin or variants thereof |
12/28/2000 | WO2000024774A3 Growth factor related molecules |
12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
12/28/2000 | DE19929364A1 New Corynebacterium glutamicum dihydroorotate dehydrogenase polypeptide and corresponding DNA useful for creating pyrimidine-producing organisms |
12/28/2000 | DE19928417A1 New gene encoding the G-protein coupled receptor hLPACR1, useful for diagnosis and gene therapy treatment of associated diseases |
12/28/2000 | CA2783140A1 Srsv detection kit |
12/28/2000 | CA2778826A1 Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
12/28/2000 | CA2397494A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator |
12/28/2000 | CA2386393A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
12/28/2000 | CA2382425A1 Interferon tau mutants and methods for making them |
12/28/2000 | CA2378687A1 Nucleotide sequences of moraxella catarrhalis genome |
12/28/2000 | CA2377648A1 Prion protein peptides and uses thereof |
12/28/2000 | CA2377639A1 The use of the protein uk 114 for inhibiting organ transplant rejection |
12/28/2000 | CA2377530A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
12/28/2000 | CA2377270A1 Cardiomyocytes with enhanced proliferative potential |
12/28/2000 | CA2377263A1 Polynucleotides and polypeptides encoded thereby |
12/28/2000 | CA2375869A1 Regulation system of expression using nuclear ppar receptors |
12/28/2000 | CA2375828A1 Sunflower anti-pathogenic proteins and genes and their uses |
12/28/2000 | CA2375791A1 Avirulent xanthomonas-campestris strains producing xanthan |
12/28/2000 | CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci |
12/28/2000 | CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1 |
12/28/2000 | CA2375527A1 Method for enhancing hematopoiesis |
12/28/2000 | CA2375508A1 Methods and products for manipulating uncoupling protein expression |
12/28/2000 | CA2375502A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
12/28/2000 | CA2375498A1 Epithelial cell growth inhibitors |
12/28/2000 | CA2375493A1 Human transport proteins |
12/28/2000 | CA2375490A1 Chimeric oca-b transcription factors |
12/28/2000 | CA2375484A1 In vivo insect model system for type-2 diabetes |
12/28/2000 | CA2375480A1 Head trauma induced cytoplasmatic calcium binding protein |
12/28/2000 | CA2375475A1 Serin proteinase inhibitors |
12/28/2000 | CA2375414A1 Human transcriptional regulator proteins |